AstraZeneca and GSK, the U.K.’s second and ninth most valuable companies, both saw first-quarter profits beat expectations early Wednesday.
UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies
Posted by
No Comments
No Comments
